TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Paras Biopharmaceuticals Finland Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
20
|
62 | |
| Financial expenses |
17
|
5
|
1 |
| Earnings before taxes |
-923
|
-421
|
-278 |
| Total assets |
3,019
|
539
|
149 |
| Current assets |
2,036
|
78
|
22 |
| Current liabilities |
483
|
346
|
241 |
| Equity capital |
2,013
|
37
|
-129 |
| - share capital |
3
|
159
|
3 |
| Employees (average) | 15 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
66.7%
|
6.9%
|
-86.6% |
| Turnover per employee | 1 | ||
| Profit as a percentage of turnover |
-4615.0%
|
-679.0% | |
| Return on assets (ROA) |
-30.0%
|
-77.2%
|
-185.9% |
| Current ratio |
421.5%
|
22.5%
|
9.1% |
| Return on equity (ROE) |
-45.9%
|
-1137.8%
|
215.5% |
| Change turnover | -42 | ||
| Change turnover % | -68% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.